Search
We are currently carrying out work to improve the usability of our search function. This may cause search results to be incomplete. We anticipate this issue will be resolved in the coming hours.
This search looks for keywords in all of the website’s content. You can also download all of our medicine data. More help: search tips
Filter by
Search results (26085)
Pharmaceutical companies with large portfolios can attend free, virtual meetings with European Medicines Agency (EMA). These meetings address development issues and anticipate future scientific and regulatory needs. They aim to support successful product portfolio development.
The Innovation Task Force (ITF) briefing meetings offer developers early dialogue with the European Medicines Agency (EMA) on innovative medicines. They address regulatory, technical and scientific concerns.
A risk minimisation measure (RMM) is intended to reduce adverse reactions of medicines, also called side effects. These measures and the risks they address feature in the product information of medicines authorised in the European Union (EU). Where needed, these measures may also feature in additional resources. The European Medicines Agency (EMA)...